Rhythm Pharmaceuticals (RYTM) Current Leases (2019 - 2026)
Rhythm Pharmaceuticals' (RYTM) quarterly Current Leases came in at $676000.0 in Q1 2026, up 201.79% year-on-year from $224000.0 in Q1 2025, and up 4.0% on a QoQ basis from $650000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Current Leases (2019 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 8 years of Current Leases data on file, last reported at $676000.0 in Q1 2026.
- On a quarterly basis, Current Leases rose 201.79% year-over-year to $676000.0 in Q1 2026; TTM through Mar 2026 was $676000.0, a 201.79% increase from a year earlier, with the FY2025 full-year figure at $650000.0, changed N/A from the prior year.
- Current Leases for Q1 2026 stood at $676000.0, up from $650000.0 in the prior quarter.
- Over the last five years, Current Leases for RYTM reached as high as $816000.0 in Q2 2024 and fell as low as $224000.0 in Q1 2025.
- Historically, Current Leases has averaged $657266.7 across 5 years, with a median of $676000.0 in 2026.
- Across the five-year window, Current Leases sank 71.75% in 2025 and jumped 201.79% in 2026, its largest moves.
- Year by year, Current Leases stood at $684000.0 in 2022, then climbed by 12.57% to $770000.0 in 2023, then increased by 5.97% to $816000.0 in 2024, then decreased by 20.34% to $650000.0 in 2025, then grew by 4.0% to $676000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $676000.0 in Q1 2026, $650000.0 in Q4 2025, and $624000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Rhythm Pharmaceuticals | 6.99 Bn | 6.64 Bn | 52.96 Mn | 676,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 676,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Sep 30, 2025 | 624,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Mar 31, 2025 | 224,000.00 |
| Jun 30, 2024 | 816,000.00 |
| Mar 31, 2024 | 793,000.00 |
| Dec 31, 2023 | 770,000.00 |
| Sep 30, 2023 | 748,000.00 |
| Jun 30, 2023 | 726,000.00 |
| Mar 31, 2023 | 705,000.00 |
| Dec 31, 2022 | 684,000.00 |
| Sep 30, 2022 | 664,000.00 |
| Jun 30, 2022 | 644,000.00 |
| Mar 31, 2022 | 625,000.00 |
| Dec 31, 2021 | 606,000.00 |
| Sep 30, 2021 | 588,000.00 |
| Jun 30, 2021 | 570,000.00 |
| Mar 31, 2021 | 553,000.00 |
| Dec 31, 2020 | 535,000.00 |